Clinical Trials Directory

Trials / Completed

CompletedNCT07004127

Pneumocystis in Patients Over 75 Year

Pneumocystis in Non-HIV Patients Over 75 Years Old: Epidemiological, Diagnostic, Microbiological and Therapeutic Characteristics

Status
Completed
Phase
Study type
Observational
Enrollment
162 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

Pneumocystis pneumonia is an infectious disease caused by Pneumocystis jirovecii that affects the lung parenchyma preferentially. Historically described in an immunocompromised population through HIV. Worldwide, the profile of patients affected by this pathology is changing due to two main factors: * The sustainable stabilization of HIV patients. * The emergence of new risk factors of immunosuppression. The geriatric population is particularly affected by these risk factors, increasing the incidence of pneumocystis in this population, which does not have HIV (solid cancer, hemopathy, immunosuppressive treatments, etc.). There is currently no work specifically studying pneumocystis in this age group. The main objective of this study is to describe the clinical, biological and therapeutic data of a cohort of geriatric patients with pneumocystis, not carrying HIV, from January 1, 2010 to December 31, 2021, in all the centers surveyed.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2025-06-04
Last updated
2025-06-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07004127. Inclusion in this directory is not an endorsement.